ZGOO Holdings Co Ltd
221800
Company Profile
Business description
ZGOO Holdings Co Ltd, formerly U2Bio Co Ltd provides in vitro diagnostic test services. The company generates revenue from vitro diagnostic testing services that include general and molecular diagnostic testing services, and medical IT solution services, which include EMR integration software for health screenings and medical institutions. The company is also pursuing new growth engines in pharmaceutical clinical trials and microbiomes.
Contact
489 Ogeum-ro
4th floor
Songpa-gu
Seoul
KORT: +82 16442068
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
100
Stocks News & Analysis
stocks
Cheap ASX share may have more room to run
Shares are cheap despite rebounding share price, yet risks remain.
stocks
ASX listed media giant drives strong earnings growth
Digital growth drives earnings beat for media share.
stocks
ASX real estate platform outperforms yet questions remain
Valuation remains a key concern despite strong August reporting.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,424.10 | 13.30 | -0.14% |
| CAC 40 | 8,722.11 | 7.18 | 0.08% |
| DAX 40 | 26,363.65 | 44.20 | 0.17% |
| Dow JONES (US) | 54,036.93 | 151.83 | 0.28% |
| FTSE 100 | 10,869.60 | 31.49 | -0.29% |
| HKSE | 25,937.49 | 269.46 | 1.05% |
| NASDAQ | 26,690.62 | 342.26 | 1.30% |
| Nikkei 225 | 66,970.22 | 1,363.51 | 2.08% |
| NZX 50 Index | 13,888.24 | 64.11 | 0.46% |
| S&P 500 | 7,757.64 | 0.00 | 0.00% |
| S&P/ASX 200 | 9,232.60 | 17.00 | -0.18% |
| SSE Composite Index | 3,966.59 | 26.56 | 0.67% |